Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enzo Biochem (NY: ENZ ) 1.060 +0.020 (+1.92%) Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enzo Biochem < Previous 1 2 3 Next > Why Is Histogen (HSTO) Stock Up 37% Today? March 17, 2023 Histogen (HSTO) stock is rising higher on Friday after getting a patent for CTS-2090 that protects its products through 2040. Via InvestorPlace Why Is Enzo Biochem (ENZ) Stock Up 72% Today? March 17, 2023 Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 17, 2023 The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! Via InvestorPlace Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket March 17, 2023 Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. Via Benzinga Why Enzo Biochem Stock Is Skyrocketing After Hours March 16, 2023 Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 16, 2023 Via Benzinga Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp March 16, 2023 From Enzo Biochem, Inc. Via GlobeNewswire Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying January 20, 2023 The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... Via Benzinga Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying January 19, 2023 The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Nasdaq Rises 100 Points; Gold Gains Over 1% December 13, 2022 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday Via Benzinga Dow Turns Lower; Crude Oil Rises Sharply December 13, 2022 U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday Via Benzinga Stocks That Hit 52-Week Lows On Tuesday December 13, 2022 On Tuesday, 49 companies hit new 52-week lows. Via Benzinga Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session December 13, 2022 Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. Via Benzinga Earnings Scheduled For December 12, 2022 December 12, 2022 Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is projected to report earnings for its second quarter. Via Benzinga Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th December 07, 2022 From Enzo Biochem, Inc. Via GlobeNewswire Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting November 08, 2022 From Enzo Biochem, Inc. Via GlobeNewswire Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW October 31, 2022 From Farmer Bros. Co. Via GlobeNewswire Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO October 20, 2022 - David Bench resigning to pursue a new career opportunity - From Enzo Biochem, Inc. Via GlobeNewswire Earnings Scheduled For October 14, 2022 October 14, 2022 Companies Reporting Before The Bell • Wells Fargo (NYSE:WFC) is estimated to report quarterly earnings at $1.08 per share on revenue of $18.77 billion. Via Benzinga Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th October 10, 2022 From Enzo Biochem, Inc. Via GlobeNewswire Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York October 06, 2022 From Enzo Biochem, Inc. Via GlobeNewswire Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday September 19, 2022 Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. Via Benzinga Earnings Scheduled For June 9, 2022 June 09, 2022 Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report quarterly loss at $0.05 per share on revenue of $14.64 million. Via Benzinga The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More June 05, 2022 Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 03, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 25, 2022 Via Benzinga Earnings Scheduled For March 14, 2022 March 14, 2022 Companies Reporting Before The Bell • F45 Training Holdings (NYSE:FXLV) is projected to report earnings for its fourth quarter. • The One Group Hospitality (... Via Benzinga The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings March 13, 2022 Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... Via Benzinga The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street December 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug... Via Benzinga The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO December 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.